Mitochondrial DNA heteroplasmy in cardiac tissue from individuals with and without coronary artery disease

References

• A Sobenin I, V Zhelankin A, Y Mitrofanov K, V Sinyov V, A Sazonova M, Y Postnov A, N Orekhov A. 2015. Mutations of mitochondrial DNA in atherosclerosis and atherosclerosis-related diseases. Curr Pharm Design. 21:1158–1163.
   PubMed Web of Science ®Google Scholar
• Ashar FN, Zhang Y, Moes A, Grove ML, Wilsdon AG, Chaves PH, Coresh J, Newman AB, Bandeen-Roche K, Boerwinkle E, et al. 2014. Abstract 19318: mitochondrial DNA copy number as a predictor of cardiovascular disease. Circulation. 130:A19318–A19318.
   Web of Science ®Google Scholar
• Bai R-K, Perng C-L, Hsu C-H, Wong L-JC. 2004. Quantitative PCR analysis of mitochondrial DNA content in patients with mitochondrial disease. Ann NY Acad Sci. 1011:304–309.
   PubMed Web of Science ®Google Scholar
• Bayeva M, Gheorghiade M, Ardehali H. 2013. Mitochondria as a therapeutic target in heart failure. J Am Coll Cardiol. 61:599–610.
   PubMed Web of Science ®Google Scholar
• Botto N, Berti S, Manfredi S, Al-Jabri A, Federici C, Clerico A, Ciofini E, Biagini A, Andreassi MG. 2005. Detection of mtDNA with 4977bp deletion in blood cells and atherosclerotic lesions of patients with coronary artery disease. Mutat Res. 570:81–88.
   PubMed Web of Science ®Google Scholar
• Chen S, Xie X, Wang Y, Gao Y, Xie X, Yang J, Ye J. 2014. Association between leukocyte mitochondrial DNA content and risk of coronary heart disease: a case-control study. Atherosclerosis. 237:220–226.
   PubMed Web of Science ®Google Scholar
• Corral-Debrinski M, Shoffner J, Lott M, Wallace D. 1992. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutat Res. 275:169–180.
   PubMed Web of Science ®Google Scholar
• Corral-Debrinski M, Stepien G, Shoffner JM, Lott MT, Kanter K, Wallace DC. 1991. Hypoxemia is associated with mitochondrial DNA damage and gene induction. Implications for cardiac disease. JAMA. 266:1812–1816.
   PubMed Web of Science ®Google Scholar
• Emma P, Bennett MR. 2014. Mitochondrial DNA damage and atherosclerosis. Trends Endocrinol Metab. 25:481–487.
   PubMed Web of Science ®Google Scholar
• Fetterman JL, Holbrook M, Westbrook DG, Brown JA, Feeley KP, Bretón-Romero R, Linder EA, Berk BD, Weisbrod RM, Widlansky ME. 2016. Mitochondrial DNA damage and vascular function in patients with diabetes mellitus and atherosclerotic cardiovascular disease. Cardiovasc Diabetol. 15:1.
   PubMed Web of Science ®Google Scholar
• Grady JP, Murphy JL, Blakely EL, Haller RG, Taylor RW, Turnbull DM, Tuppen HAL. 2014. Accurate measurement of mitochondrial DNA deletion level and copy number differences in human skeletal muscle. Plos One. 9:e114462.
   PubMed Web of Science ®Google Scholar
• Hansson GK. 2005. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 352:1685–1695.
   PubMed Web of Science ®Google Scholar
• He Y, Wu J, Dressman DC, Iacobuzio-Donahue C, Markowitz SD, Velculescu VE, Diaz LA, Jr Kinzler KW, Vogelstein B, Papadopoulos N. 2010. Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. Nature. 464:610–614.
   PubMed Web of Science ®Google Scholar
• Hefti E, Bard J, Blanco JG. 2017. Analysis of heteroplasmic variants in the cardiac mitochondrial genome of individuals with down syndrome. Hum Mutat. 38:48–54.
   PubMed Web of Science ®Google Scholar
• Hefti E, Quiñones-Lombraña A, Redzematovic A, Hui J, Blanco JG. 2016. Analysis of mtDNA, miR-155 and BACH1 expression in hearts from donors with and without Down syndrome. Mitochondrial DNA A DNA Mapp Seq Anal. 27:896–903.
   PubMedGoogle Scholar
• Huang J, Tan L, Shen R, Zhang L, Zuo H, Wang DW. 2016. Decreased peripheral mitochondrial DNA copy number is associated with the risk of heart failure and long-term outcomes. Medicine. 95:1–10.
   Web of Science ®Google Scholar
• Lin MT, Beal MF. 2006. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 443:787–795.
   PubMed Web of Science ®Google Scholar
• Lucas DT, Szweda LI. 1998. Cardiac reperfusion injury: aging, lipid peroxidation, and mitochondrial dysfunction. Proc Natl Acad Sci. 95:510–514.
   PubMed Web of Science ®Google Scholar
• Madamanchi NR, Runge MS. 2007. Mitochondrial dysfunction in atherosclerosis. Circ Res. 100:460–473.
   PubMed Web of Science ®Google Scholar
• Mensah GA, Brown DW. 2007. An overview of cardiovascular disease burden in the United States. Health Aff. 26:38–48.
   PubMed Web of Science ®Google Scholar
• Mikhed Y, Daiber A, Steven S. 2015. Mitochondrial oxidative stress, mitochondrial DNA damage and their role in age-related vascular dysfunction. Int J Mol Sci. 16:15918–15953.
   PubMed Web of Science ®Google Scholar
• Sharma H, Singh A, Sharma C, Jain SK, Singh N. 2005. Mutations in the mitochondrial DNA D-loop region are frequent in cervical cancer. Cancer Cell Int. 5:34.
   PubMed Web of Science ®Google Scholar
• Stewart JB, Chinnery PF. 2015. The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease. Nat Rev Genet. 16:530–542.
   PubMed Web of Science ®Google Scholar
• Stoneking M. 2000. Hypervariable sites in the mtDNA control region are mutational hotspots. Am J Hum Genet. 67:1029–1032.
   PubMed Web of Science ®Google Scholar
• Tang S, Huang T. 2010. Characterization of mitochondrial DNA heteroplasmy using a parallel sequencing system. Biotechniques. 48:287–296.
   PubMed Web of Science ®Google Scholar
• Taylor RW, Turnbull DM. 2005. Mitochondrial DNA mutations in human disease. Nat Rev Genet. 6:389–402.
   PubMed Web of Science ®Google Scholar
• Venegas V, Wang J, Dimmock D, Wong LJ. 2011. Real‐time quantitative PCR analysis of mitochondrial DNA content. Curr Protoc Hum Genet. 68:19.7.1–19.7.12.
   Google Scholar
• Xing J, Chen M, Wood CG, Lin J, Spitz MR, Ma J, Amos CI, Shields PG, Benowitz NL, Gu J, et al. 2008. Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma. J Natl Cancer Inst. 100:1104–1112.
   PubMedGoogle Scholar
• Ye K, Lu J, Ma F, Keinan A, Gu Z. 2014. Extensive pathogenicity of mitochondrial heteroplasmy in healthy human individuals. Proc Natl Acad Sci USA. 111:10654–10659.
   PubMed Web of Science ®Google Scholar